I don't think we're too far off 'market darling' status to be...

I don't think we're too far off 'market darling' status to be honest.. once the options offer finishes we will hear more around the investigator trial and with the recent pre clinical data I'm very curious. Tox is going to be wrapping up very soon if not already happening, and all the other work leading to trials is underway as far as I know. The mention on the webinar yesterday re market cycles for bio tech I thought was a timely reminder too, we do need a few stars to align but it's certainly shaping up to be the perfect storm. I, like you am happy to grab a few more at these prices while the market waits for confirmation. Normally i'd say its better to wait for confirmation but with bis been de risked as it is, in my opinion makes it a better bet if you've done your own research and looked at the risk/reward. (from the perspective of FA).